Miejsce gotowych połączeń lekowych w terapii hipotensyjnej

Zbigniew Gaciong

ISSN: 1505-8409

Przewodnik Lekarza/Guide for GPs

Current issue Archive About the journal Supplements Abstracting and indexing Contact Instructions for authors

4/2010
vol. 13

Send email

Copy url:

abstract:

Miejsce gotowych połączeń lekowych w terapii hipotensyjnej

Zbigniew Gaciong

Online publish date: 2010/12/17

View full text Get citation

It is evident that blood pressure reduction per se is the primary determinant of cardiovascular risk reduction. Available data suggest that at least 75% of patients will require combination therapy to achieve contemporary blood presure targets, and increasing emphasis is being placed on the practical tasks involved in consistently achieving and maintaining goal BP in clinical practice. This review will address the scientific basis of combination therapy, present the pharmacologic rationale for choosing specific drug combinations, and review patient selection criteria for initial and secondary use. The advantages and disadvantages of single pill (fixed) drug combinations, and the implications of recent clinical trials involving specific combination strategies will also be discussed.

keywords:

Miejsce gotowych połączeń lekowych w terapii hipotensyjnej

Zbigniew Gaciong

combination therapy, antihypertensive drugs, goal blood pressure